Topics

Swedish Ulcerative Colitis Treatment Makes Phase II Comeback

10:10 EDT 27 Aug 2019 | Labiotech.eu

InDex Pharmaceuticalsulcerative colitis drug candidate has achieved positive phase IIb results, suggesting work to improve its dosage after a previous phase III failure was successful.  The Swedish company tested different doses of the small molecule drug cobitolimod against a placebo in patients with the inflammatory bowel disease ulcerative colitis. The 213 patients in the […]

The post Swedish Ulcerative Colitis Treatment Makes Phase II Comeback appeared first on Labiotech.eu.

Original Article: Swedish Ulcerative Colitis Treatment Makes Phase II Comeback

NEXT ARTICLE

More From BioPortfolio on "Swedish Ulcerative Colitis Treatment Makes Phase II Comeback"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...